Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 23949920)

1.

Nuclear localization of the transcriptional coactivator YAP is associated with invasive lobular breast cancer.

Vlug EJ, van de Ven RA, Vermeulen JF, Bult P, van Diest PJ, Derksen PW.

Cell Oncol (Dordr). 2013 Oct;36(5):375-84. doi: 10.1007/s13402-013-0143-7. Epub 2013 Aug 15.

2.

Nuclear Kaiso expression is associated with high grade and triple-negative invasive breast cancer.

Vermeulen JF, van de Ven RA, Ercan C, van der Groep P, van der Wall E, Bult P, Christgen M, Lehmann U, Daniel J, van Diest PJ, Derksen PW.

PLoS One. 2012;7(5):e37864. doi: 10.1371/journal.pone.0037864. Epub 2012 May 25.

3.

YAP expression in normal and neoplastic breast tissue: an immunohistochemical study.

Jaramillo-Rodríguez Y, Cerda-Flores RM, Ruiz-Ramos R, López-Márquez FC, Calderón-Garcidueñas AL.

Arch Med Res. 2014 Apr;45(3):223-8. doi: 10.1016/j.arcmed.2014.01.010. Epub 2014 Mar 4. Erratum in: Arch Med Res. 2014 Aug;45(6):514.

PMID:
24606817
4.

Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility.

Wang Z, Wu Y, Wang H, Zhang Y, Mei L, Fang X, Zhang X, Zhang F, Chen H, Liu Y, Jiang Y, Sun S, Zheng Y, Li N, Huang L.

Proc Natl Acad Sci U S A. 2014 Jan 7;111(1):E89-98. doi: 10.1073/pnas.1319190110. Epub 2013 Dec 23.

5.

The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity.

Shimomura T, Miyamura N, Hata S, Miura R, Hirayama J, Nishina H.

Biochem Biophys Res Commun. 2014 Jan 17;443(3):917-23. doi: 10.1016/j.bbrc.2013.12.100. Epub 2013 Dec 28.

PMID:
24380865
6.

Expression of nuclear insulin receptor substrate 1 in breast cancer.

Sisci D, Morelli C, Garofalo C, Romeo F, Morabito L, Casaburi F, Middea E, Cascio S, Brunelli E, Andò S, Surmacz E.

J Clin Pathol. 2007 Jun;60(6):633-41. Epub 2006 Aug 1.

7.

Nuclear localization and cytosolic overexpression of LASP-1 correlates with tumor size and nodal-positivity of human breast carcinoma.

Grunewald TG, Kammerer U, Kapp M, Eck M, Dietl J, Butt E, Honig A.

BMC Cancer. 2007 Oct 23;7:198.

8.

The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain.

Lamar JM, Stern P, Liu H, Schindler JW, Jiang ZG, Hynes RO.

Proc Natl Acad Sci U S A. 2012 Sep 11;109(37):E2441-50. doi: 10.1073/pnas.1212021109. Epub 2012 Aug 13.

9.

Expression of Yes-associated protein in non-small cell lung cancer and its relationship with clinical pathological factors.

Su LL, Ma WX, Yuan JF, Shao Y, Xiao W, Jiang SJ.

Chin Med J (Engl). 2012 Nov;125(22):4003-8.

PMID:
23158133
10.

Yes-associated protein is not an independent prognostic marker in breast cancer.

Sheen-Chen SM, Huang CY, Tsai CH, Liu YW, Wu SC, Huang CC, Eng HL, Chan YC, Ko SF, Tang RP.

Anticancer Res. 2012 Aug;32(8):3321-5.

PMID:
22843909
11.

E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.

Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO.

Histopathology. 2005 Jun;46(6):685-93.

PMID:
15910600
12.

TEAD mediates YAP-dependent gene induction and growth control.

Zhao B, Ye X, Yu J, Li L, Li W, Li S, Yu J, Lin JD, Wang CY, Chinnaiyan AM, Lai ZC, Guan KL.

Genes Dev. 2008 Jul 15;22(14):1962-71. doi: 10.1101/gad.1664408. Epub 2008 Jun 25.

13.
14.

Mutual inhibition between YAP and SRSF1 maintains long non-coding RNA, Malat1-induced tumourigenesis in liver cancer.

Wang J, Wang H, Zhang Y, Zhen N, Zhang L, Qiao Y, Weng W, Liu X, Ma L, Xiao W, Yu W, Chu Q, Pan Q, Sun F.

Cell Signal. 2014 May;26(5):1048-59. doi: 10.1016/j.cellsig.2014.01.022. Epub 2014 Jan 25.

PMID:
24468535
15.

Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma.

Gonzalez-Angulo AM, Sahin A, Krishnamurthy S, Yang Y, Kau SW, Hortobagyi GN, Cristofanilli M.

Clin Breast Cancer. 2006 Dec;7(5):396-400.

PMID:
17239264
16.

EZH2 expression in invasive lobular carcinoma of the breast.

Roh S, Park SY, Ko HS, Sohn JS, Cha EJ.

World J Surg Oncol. 2013 Nov 22;11:299. doi: 10.1186/1477-7819-11-299.

17.

Angiomotin'g YAP into the nucleus for cell proliferation and cancer development.

Hong W.

Sci Signal. 2013 Sep 3;6(291):pe27. doi: 10.1126/scisignal.2004573. Review.

PMID:
24003252
18.

Changes in subcellular localisation of MI-ER1 alpha, a novel oestrogen receptor-alpha interacting protein, is associated with breast cancer progression.

McCarthy PL, Mercer FC, Savicky MW, Carter BA, Paterno GD, Gillespie LL.

Br J Cancer. 2008 Aug 19;99(4):639-46. doi: 10.1038/sj.bjc.6604518. Epub 2008 Jul 29.

19.

Loss of Yes-associated protein (YAP) expression is associated with estrogen and progesterone receptors negativity in invasive breast carcinomas.

Tufail R, Jorda M, Zhao W, Reis I, Nawaz Z.

Breast Cancer Res Treat. 2012 Feb;131(3):743-50. doi: 10.1007/s10549-011-1435-0. Epub 2011 Mar 12.

20.

Automated image analysis of cyclin D1 protein expression in invasive lobular breast carcinoma provides independent prognostic information.

Tobin NP, Lundgren KL, Conway C, Anagnostaki L, Costello S, Landberg G.

Hum Pathol. 2012 Nov;43(11):2053-61. doi: 10.1016/j.humpath.2012.02.015. Epub 2012 May 29.

PMID:
22647349
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk